XUNFEIHEALTH (02506) released its Monthly Return for Equity Issuer and Hong Kong Depositary Receipts for the period ended 28 February 2026. The company's total registered share capital remained RMB120.88 million, comprising two classes of ordinary shares: unlisted shares (43.58 million shares) and H shares (77.30 million shares), both with a par value of RMB1 each, unchanged from the preceding month.

The report confirms that the applicable public float requirement of 15.67% has been satisfied, with no issuance of new shares, repurchase of shares, or changes to treasury shares announced during this period. The confirmation also states that all relevant regulatory and listing requirements have been met, with no outstanding adjustments or movements affecting the total number of issued shares.

No stock options, warrants, convertibles, or other agreements to issue shares were noted in the latest filing.